Individualizing HCV Treatment with Peginterferon and Ribavirin: What needs to be Done?

Por Jensen, Donald M.
Publicado em 2009

Advances in Combination Regimens in the Management of HCV Infection

Por Jensen, Donald M.
Publicado em 2014

Mechanism of Action of Ribavirin in the Treatment of Chronic Hepatitis C

Por Te, Helen S., Randall, Glenn, Jensen, Donald M.
Publicado em 2007

A New-Onset Rash in the Setting of Rifaximin Treatment for Hepatic Encephalopathy

Por Fritz, Cassandra D.L., Adebajo, Corlan, Aronsohn, Andrew, Jensen, Donald M.
Publicado no ACG Case Rep J (2014)

Early Predictors of Anemia in Patients with Hepatitis C Genotype 1 Treated with Peginterferon alfa-2a (40KD) plus Ribavirin

Por Reau, Nancy, Hadziyannis, Stephanos J., Messinger, Diethelm, Fried, Michael W., Jensen, Donald M.
Publicado em 2008

Lack of Efficacy of Pegylated Interferon Monotherapy for Hepatitis C in Patients With End-Stage Renal Disease on Dialysis

Por Sauk, Jenny, Jensen, Donald M., Mohanty, Smruti R., Reau, Nancy, Reddy, K. Gautham, Te, Helen S.
Publicado no Gastroenterol Hepatol (N Y) (2006)

Physicians' preference values for hepatitis C health states and antiviral therapy: A survey

Por Patil, Raj, Cotler, Scott J, Banaad-Omiotek, Geraldine, McNutt, Robert A, Brown, Michael D, Cotler, Sheldon, Jensen, Donald M
Publicado em 2001

Hepatitis C Virus: A Critical Appraisal of New Approaches to Therapy

Por Nelson, David R., Jensen, Donald M., Sulkowski, Mark S., Everson, Greg, Fried, Michael W., Gordon, Stuart C., Jacobson, Ira, Reau, Nancy S., Sherman, Kenneth, Terrault, Nora, Thomas, David
Publicado em 2012

Retinoid and carotenoid status in serum and liver among patients at high-risk for liver cancer

Por Kataria, Yachana, Deaton, Ryan J., Enk, Erika, Jin, Ming, Petrauskaite, Milita, Dong, Linlin, Goldenberg, Joseph R., Cotler, Scott J., Jensen, Donald M., van Breemen, Richard B., Gann, Peter H.
Publicado no BMC Gastroenterol (2016)

Discovery of a Novel Human Pegivirus in Blood Associated with Hepatitis C Virus Co-Infection

Por Berg, Michael G., Lee, Deanna, Coller, Kelly, Frankel, Matthew, Aronsohn, Andrew, Cheng, Kevin, Forberg, Kenn, Marcinkus, Marilee, Naccache, Samia N., Dawson, George, Brennan, Catherine, Jensen, Donald M., Hackett, John, Chiu, Charles Y.
Publicado no PLoS Pathog (2015)

Balapiravir plus peginterferon alfa-2a (40KD)/ribavirin in a randomized trial of hepatitis C genotype 1 patients()

Por Nelson, David R., Zeuzem, Stefan, Andreone, Pietro, Ferenci, Peter, Herring, Robert, Jensen, Donald M., Marcellin, Patrick, Pockros, Paul J., Rodríguez-Torres, Maribel, Rossaro, Lorenzo, Rustgi, Vinod K., Sepe, Thomas, Sulkowski, Mark, Thomason, Isaac R., Yoshida, Eric M., Chan, Anna, Hill, George
Publicado em 2012